Delivery Order SPE2DB24D2205-SPE2DB24FDXKL
- Not listed
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $7,319.00 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on July 8, 2024 with a completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $2,659.10 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024, with a period of performance through November 27, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,850.00 firm fixed-price delivery order is for the supply of BOOSTRIX TDAP vaccine syringes (0.5 mL). The contract has an ultimate completion date of December 8, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- The federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is a delivery order valued at $5,322.00. The contract has a firm fixed price and an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $14,732.20, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of September 12, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,848.26 firm fixed-price delivery order is for the BOOSTRIX TDAP vaccine syringe, 0.5 mL. The contract has a completion date of May 5, 2023 and was awarded on May 4, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $2,612.30 fixed-price delivery order contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,904.70 firm-fixed-price delivery order is for the supply of BOOSTRIX TDAP vaccine syringes. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $2,062.24 firm fixed price delivery order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of...
- The federal contract award is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency. The firm fixed-price contract has a ceiling value of $5,597.04 and an ultimate completion date of May 19, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set-aside and represents an open competition award. Amerisourcebergen Drug Corp also holds a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDXKLDelivery Order
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGES 0.5ML to the Defense Logistics Agency (DLA). The $11,135.52 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 25, 2024. The contract has an ultimate completion date of July 26, 2024 and is not designated as a set-aside. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery vehicles (IDVs) by the DLA and other agencies to supply a wide range of pharmaceutical products and medical supplies to support various government healthcare programs and facilities, including military treatment centers. These include a $999,999,999 IDC with DLA Troop Support Medical through 2025 and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation through 2024 for medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 7/25/24 |